<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01609270</url>
  </required_header>
  <id_info>
    <org_study_id>MCV00008317</org_study_id>
    <nct_id>NCT01609270</nct_id>
  </id_info>
  <brief_title>CardioRoot Post-Marketing Surveillance Registry</brief_title>
  <acronym>CardioRoot</acronym>
  <official_title>CardioRoot Post-Marketing Surveillance Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maquet Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maquet Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-marketing surveillance registry of the CardioRoot graft.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objective is to monitor the performance and safety of CardioRoot vascular grafts
      implanted in a thoracic position. Patient survival rates will be monitored as well as
      immediate and long-term complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Graft complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications will be assessed out to one year post implantation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Graft complications</measure>
    <time_frame>1 year</time_frame>
    <description>Complications will be assessed out to one year post implantation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject mortality rate</measure>
    <time_frame>30 days, 1 year</time_frame>
    <description>Subject mortality rate will be followed out to one year post implantation.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Cardiovascular Surgical Procedure</condition>
  <arm_group>
    <arm_group_label>CardioRoot</arm_group_label>
    <description>All subjects receive the CardioRoot graft at baseline implant procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CardioRoot graft</intervention_name>
    <description>prospective single arm multi-center study to evaluate CardioRoot grafts implanted in a thoracic position.</description>
    <arm_group_label>CardioRoot</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aneurysmal and occlusive disease of the thoracic aorta treated with a
        CARDIOROOT vascular graft.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients requiring a CardioRoot graft as per the CardioRoot Instructions for Use (IFU)

        Exclusion Criteria:

          -  patients with contra-indications per CardioRoot IFU

          -  patients requiring consecutive aortic surgery

          -  patients with coronary artery disease

          -  patients who require urgent or emergent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General University Hospital</name>
      <address>
        <city>Prague</city>
        <zip>128 08</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Prague</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire (CHU) de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33404</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Manzoni di Lecco</name>
      <address>
        <city>Lecco</city>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Luigi Sacco</name>
      <address>
        <city>Milano</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>France</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
    <country>Germany</country>
  </removed_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>May 25, 2012</study_first_submitted>
  <study_first_submitted_qc>May 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2012</study_first_posted>
  <last_update_submitted>September 13, 2018</last_update_submitted>
  <last_update_submitted_qc>September 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

